User profiles for Ron Korn
Ron KornRadiology Verified email at imagingendpoints.com Cited by 1079 |
[HTML][HTML] Gemcitabine plus nab-paclitaxel is an active regimen in patients with advanced pancreatic cancer: a phase I/II trial
…, DA Laheru, LS Smith, TE Wood, RL Korn… - Journal of Clinical …, 2011 - ncbi.nlm.nih.gov
Purpose The trial objectives were to identify the maximum-tolerated dose (MTD) of first-line
gemcitabine plus nab-paclitaxel in metastatic pancreatic adenocarcinoma and to provide …
gemcitabine plus nab-paclitaxel in metastatic pancreatic adenocarcinoma and to provide …
Amyloid-β assessed by florbetapir F 18 PET and 18-month cognitive decline: a multicenter study
Objectives: Florbetapir F 18 PET can image amyloid-β (Aβ) aggregates in the brains of living
subjects. We prospectively evaluated the prognostic utility of detecting Aβ pathology using …
subjects. We prospectively evaluated the prognostic utility of detecting Aβ pathology using …
First-in-humans imaging with 89Zr-Df-IAB22M2C anti-CD8 minibody in patients with solid malignancies: preliminary pharmacokinetics, biodistribution, and lesion …
Immunotherapy is becoming the mainstay for treatment of a variety of malignancies, but only
a subset of patients responds to treatment. Tumor-infiltrating CD8-positive (CD8+) T …
a subset of patients responds to treatment. Tumor-infiltrating CD8-positive (CD8+) T …
CD8-targeted PET imaging of tumor-infiltrating T cells in patients with cancer: a phase I first-in-humans study of 89Zr-Df-IAB22M2C, a radiolabeled anti-CD8 minibody
There is a need for in vivo diagnostic imaging probes that can noninvasively measure tumor-infiltrating
CD8+ leukocytes. Such imaging probes could be used to predict early response …
CD8+ leukocytes. Such imaging probes could be used to predict early response …
Safety and feasibility of autologous myoblast transplantation in patients with ischemic cardiomyopathy: four-year follow-up
…, M Yeager, V Dilsizian, BP Griffith, R Korn… - Circulation, 2005 - Am Heart Assoc
Background— Successful autologous skeletal myoblast transplantation into infarcted
myocardium in a variety of animal models has demonstrated improvement in cardiac function. We …
myocardium in a variety of animal models has demonstrated improvement in cardiac function. We …
Phase Ib study of PEGylated recombinant human hyaluronidase and gemcitabine in patients with advanced pancreatic cancer
…, SA Tjulandin, OA Gladkov, RF Holcombe, R Korn… - Clinical Cancer …, 2016 - AACR
Purpose: This phase Ib study evaluated the safety and tolerability of PEGylated human
recombinant hyaluronidase (PEGPH20) in combination with gemcitabine (Gem), and established …
recombinant hyaluronidase (PEGPH20) in combination with gemcitabine (Gem), and established …
[PDF][PDF] A computed tomography radiogenomic biomarker predicts microvascular invasion and clinical outcomes in hepatocellular carcinoma
…, DS Wang, HJ Kim, CB Sirlin, MG Chan, RL Korn… - …, 2015 - Wiley Online Library
Microvascular invasion (MVI) in hepatocellular carcinoma (HCC) is an independent predictor
of poor outcomes subsequent to surgical resection or liver transplantation (LT); however, …
of poor outcomes subsequent to surgical resection or liver transplantation (LT); however, …
Safety and activity of RRx-001 in patients with advanced cancer: a first-in-human, open-label, dose-escalation phase 1 study
…, SJ Knox, S Ning, DM Peehl, R Korn… - The Lancet …, 2015 - thelancet.com
Background Epigenetic alterations have been strongly associated with tumour formation and
resistance to chemotherapeutic drugs, and epigenetic modifications are an attractive target …
resistance to chemotherapeutic drugs, and epigenetic modifications are an attractive target …
[HTML][HTML] Adenosquamous carcinoma of the pancreas: Molecular characterization of 23 patients along with a literature review
Adenosquamous carcinoma of the pancreas (ASCP) is a rare entity. Like adenocarcinoma
of the pancreas, overall survival is poor. Characteristics of ASCP include central tumor …
of the pancreas, overall survival is poor. Characteristics of ASCP include central tumor …
MicroRNA‐328 is associated with (non‐small) cell lung cancer (NSCLC) brain metastasis and mediates NSCLC migration
Brain metastasis (BM) can affect ∼ 25% of nonsmall cell lung cancer (NSCLC) patients during
their lifetime. Efforts to characterize patients that will develop BM have been disappointing…
their lifetime. Efforts to characterize patients that will develop BM have been disappointing…